Results for rasburicase translation from English to Estonian

rasburicase
rasburikaas

fasturtec rasburicase
dutrebis lamivudiin/raltegraviir

rasburicase 1.5 mg/1 ml
rasburikaas 1,5 mg/1 ml.

solvent for rasburicase 1.5 mg
lahusti 1,5 mg rasburikaasile.

rasburicase is a protein, and therefore:
rasburikaas on valk, mistõttu:

fasturtec contains the active ingredient rasburicase.
fasturtec sisaldab toimeainena rasburikaasi.

rasburicase solution should be infused over 30 minutes.
rasburikaasi lahust tuleb manustada 30 minutilise intravenoosse infusioonina.

rasburicase produced by genetechnology in saccharomyces cerevisiae strain
rasburikaasi toodetakse geenitehnoloogia abil saccharomyces cerevisiae tüvest.

no data comparing adenuric with rasburicase are currently available.
adenuricut ja rasburikaasi võrdlevaid andmeid ei ole saada.

it is unknown whether rasburicase is excreted in human milk.
ei ole teada, kas rasburikaas eritub rinnapiima.

fasturtec is a medicine that contains the active substance rasburicase.
hindamisaruandes ei anta dutrebise kasutamise praktilisi nõuandeid.

1 vial of 7.5 mg rasburicase and 1 ampoule of 5 ml solvent.
1 viaal 7,5 mg rasburikaasiga ja 1 ampull 5 ml lahustiga.

3 vials of 1.5 mg rasburicase and 3 ampoules of 1 ml solvent.
3 viaali 1,5 mg rasburikaasiga ja 3 ampulli 1 ml lahustiga.

pack of 1 vial of 7.5 mg rasburicase and 1 ampoule of 5 ml solvent.
pakend, milles on 1 viaal 7,5 mg rasburikaasiga ja 1 ampull 5 ml lahustiga.

pack of 3 vials of 1.5 mg rasburicase and 3 ampoules of 1 ml solvent.
pakend, milles on 3 viaali 1,5 mg rasburikaasiga ja 3 ampulli 1 ml lahustiga.

rasburicase is a tetrameric protein with identical subunits of a molecular mass of about 34 kda.
rasburikaas on tetrameerne valk identsete alaühikutega, mille molekulmass on ligikaudu 34 kda.

fasturtec 1.5 mg/ ml powder for concentrate for solution for infusion rasburicase intravenous use
fasturtec 1, 5 mg/ ml pulber infusioonilahuse kontsentraadi valmistamiseks rasburikaas intravenoosne

anti-rasburicase antibodies have been detected in treated patients and healthy volunteers administered rasburicase.
rasburikaasiga ravitud patsientidel ja tervetel vabatahtlikel on leitud rasburikaasi vastaseid antikehasid.

rasburicase being an enzyme itself, it would be an unlikely candidate for drug-drug interactions.
kuna rasburikaas on ise ensüüm, ei anna ta ilmselt koostoimeid teiste ravimitega.

minimal accumulation of rasburicase (<1.3 fold) was observed between days 1 and 5 of dosing.
rasburikaasi minimaalset akumulatsiooni (<1,3 korda) täheldati annustamise 1...5 päeval.